Should HDL cholesterol levels be the primary target of cardiovascular disease risk assessment and therapy?

Avishay Elis

doi:10.1586/erc.12.39

Should HDL cholesterol levels be the primary target of cardiovascular disease risk assessment and therapy?

Avishay Elis^*

^*Corresponding author for this work

Internal Medicine

Meir Hospital Sapir Medical Center

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	675-677
Number of pages	3
Journal	Expert Review of Cardiovascular Therapy
Volume	10
Issue number	6
DOIs	https://doi.org/10.1586/erc.12.39
State	Published - Jun 2012

Keywords

HDL-C
LDL-C
atherosclerosis
cardiovascular morbidity
cardiovascular mortality
target

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1586/erc.12.39

Cite this

@article{336f29b1224b49bfb9be7dfcdfd8a35f,

title = "Should HDL cholesterol levels be the primary target of cardiovascular disease risk assessment and therapy?",

keywords = "HDL-C, LDL-C, atherosclerosis, cardiovascular morbidity, cardiovascular mortality, target",

author = "Avishay Elis",

year = "2012",

month = jun,

doi = "10.1586/erc.12.39",

language = "אנגלית",

volume = "10",

pages = "675--677",

journal = "Expert Review of Cardiovascular Therapy",

issn = "1477-9072",